课题基金 / 基金详情

Structure and function of VEGF receptors related to preeclampsia.

Structure and function of VEGF receptors related to preeclampsia.
与先兆子痫相关的 VEGF 受体的结构和功能。
批准号:
17390110
负责人:
SHIBUYA Masabumi
金额:
$8.38万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (B)
财政年份:
2005
资助国家:
日本
项目状态:
已结题
起止时间:
2005 至 2006

项目摘要

项目成果

SHIBUYA Masabumi的其他基金

相似基金

相关文献

中文摘要
翻译
子痫前期是妇科的主要疾病。近年来的研究表明,可溶性Flt-1(sFlt-1/sVEGFR 1)与该病密切相关。我们试图了解Flt-1蛋白包括sFlt-1.1的全部功能。我们发现滋养层干细胞(trophoblast stem cell,TS细胞)系统可以作为Flt-1基因表达的良好模型,因为在胎盘中,滋养层细胞是sFlt-1的主要生产者。在分化过程中,flt-1 mRNA升高5倍,表明生理基因表达。然而,我们没有发现异常上调sflt-l表达的应激。研究了外源性VEGF-A和sFlt-1对妊娠小鼠的影响。我们发现外源性VEGF-A可引起胎盘组织病理变化,如纤维蛋白沉积,外源性sFlt-1可引起一过性高血压和蛋白尿。然而,为了维持这些表型,似乎需要大量的sFlt-1。3,sFlt-1蛋白有效地阻断腹水肿瘤异常分泌的VEGF-A,导致腹水体积和腹水中肿瘤生长的抑制。因此,sFlt-1蛋白是病理性VEGF-A和腹水肿瘤抑制剂的良好候选物。(Flt-1 TK-/-小鼠)在关节炎模型中表现出较温和的表型,表明Flt-1的酪氨酸激酶是治疗类风湿关节炎的新靶点。Ambati博士的小组与我们合作发现sFlt-1- 1是维持角膜无血管性的重要天然分子。
英文摘要
Preeclampsia is a major disease in gynecological field. Recent studies strongly suggest that soluble form of Flt-1 (sFlt-1/sVEGFR1) is deeply involved in this disease. We attempted to understand the whole functions of Flt-1 protein including sFlt-1.1, We found that trophoblast stem cell (TS cell) system could be a good model for flt-1 gene expression, since in placenta, trophoblast cells are the major producer for sFlt-1. During the differentiation, flt-1 mRNA was 5-fold elevated, suggesting a physiological gene expression. However, we could not find a stress which abnormally upregulate the expression of sflt-l. Such a stress could be a candidate for inducer of preeclampsia.2, We examined the effect of exogenous VEGF-A and sFlt-1 on pregnant mice. We found that exogenous VEGF-A induces pathological change at placenta such as fibrin deposition, and exogenous sFlt-1 transiently induces hypertension and proteinurea. However, to maintain these phenotypes, a large amount of sFlt-1 appears to be required.3, sFlt-1 protein efficiently blocked abnormally secreted VEGF-A from ascites tumors, resulting in suppression of ascites volume and tumor growth in ascites. Thus, sFlt-1 protein is a good candidate for an inhibitor of pathological VEGF-A and ascites tumor.4, Flt-1 signaling-deficient mice (Flt-1 TK-/- mice) showed a milder phenotype in arthritis-model, indicating that tyrosine kinase of Flt-1 is a new target for the treatment of rheumatoid arthritis.Dr.Ambati' s group collaborating with us found that sFlt-1 is an important natural molecule for maintaining avascularity in cornea.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Signaling of vascular endothelial growth factor receptor-1 tyrosine kinase promotes rheumatoid arthritis through activation of monocyte/macrophages.
血管内皮生长因子受体 1 酪氨酸激酶的信号传导通过单核细胞/巨噬细胞的激活促进类风湿性关节炎。
DOI: --
发表时间: 2006
期刊: Blood 108
影响因子: --
作者: [Murakami, M., Iwai, S., Hiratsuka, S., Yamauchi, M., Nakamura, K., Iwakura, Y., Shibuya, M]
通讯作者: M
Vascular endothelial growth factor receptor-1 signaling is essential for osteoclast development and bone-marrow formation in CSF-1-deficient mice.
血管内皮生长因子受体 1 信号传导对于 CSF-1 缺陷小鼠的破骨细胞发育和骨髓形成至关重要。
DOI: --
发表时间: 2005
期刊: Proc. Natl. Acad. Sci. USA 102
影响因子: --
作者: [Niida, S., Kondo, T., Hiratsuka, S., Hayashi, S. -I., Amizuka, N., Noda, T., Ikeda, K., Shibuya, M]
通讯作者: M
DOI: 10.1038/nature05249
发表时间: 2006-10-26
期刊: NATURE
影响因子: 64.8
作者: [Ambati, Balamurali K., Nozaki, Miho, Singh, Nirbhai, Takeda, Atsunobu, Jani, Pooja D., Suthar, Tushar, Albuquerque, Romulo J. C., Richter, Elizabeth, Sakurai, Eiji, Newcomb, Michael T., Kleinman, Mark E., Caldwell, Ruth B., Lin, Qing, Ogura, Yuichiro, Orecchia, Angela, Samuelson, Don A., Agnew, Dalen W., St. Leger, Judy, Green, W. Richard, Mahasreshti, Parameshwar J., Curiel, David T., Kwan, Donna, Marsh, Helene, Ikeda, Sakae, Leiper, Lucy J., Collinson, J. Martin, Bogdanovich, Sasha, Khurana, Tejvir S., Shibuya, Masabumi, Baldwin, Megan E., Ferrara, Napoleone, Gerber, Hans-Peter, De Falco, Sandro, Witta, Jassir, Baffi, Judit Z., Raisler, Brian J., Ambati, Jayakrishna]
通讯作者: Ambati, Jayakrishna
VEGF-A is involved in guidance of VEGF-receptor-positive cells to the anterior portion of early embryos.
VEGF-A 参与将 VEGF 受体阳性细胞引导至早期胚胎的前部。
DOI: --
发表时间: 2005
期刊: Mol. Cell. Biol. 25
影响因子: --
作者: [Hiratsuka, S., Kataoka, Y., Nakao, K., Nakamura, K., Morikawa, S., Tanaka, S., Katsuki, M., Maru, Y., Shibuya, M]
通讯作者: M
7
    Signaling mechanism of tumor angiogenesis.
    Signal transduction for cell proliferation, apoptosis and differentiation via receptor-type tyrosine kinase and Shc molecule.
    • 批准号:
      10680662
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $2.5万
    • 财政年份:
      1998
    • 负责人:
      SHIBUYA Masabumi
    • 依托单位:
    Signal Transduction of Vascular Endothelial Cell-specific Growth Factor Receptors.
    • 批准号:
      08458226
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $3.46万
    • 财政年份:
      1996
    • 负责人:
      SHIBUYA Masabumi
    • 依托单位:
    国内基金
    海外基金
    基于VEGF/VEGFR信号通路探讨自拟创疡膏对慢性创面的作用机制研究
    • 批准号:
      2026JJ80680
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2026
    • 负责人:
      姜平
    • 依托单位:
    协同靶向VE-PTP/VEGF重建胶质母细胞瘤血管稳态的双靶点抑制剂开发与机制研究
    • 批准号:
      JCZRLH202601503
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2026
    • 负责人:
    • 依托单位:
    RNA 结合蛋白HuR与VEGF-D联合调控舌鳞癌侵袭及转移机制的研究
    • 批准号:
      2026JJ80684
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2026
    • 负责人:
      龚攀
    • 依托单位: